GSK to acquire Sierra Oncology for US $1.9bn
Momelotinib complements GSK’s existing expertise in haematology, with Sierra Oncology anticipating US regulatory submission in Q2 this year and EU submission in the second half of 2022
Momelotinib complements GSK’s existing expertise in haematology, with Sierra Oncology anticipating US regulatory submission in Q2 this year and EU submission in the second half of 2022
The initial courses of Lap. Hernia Masterclass will encompass commonly performed hernia procedures
The ultrasound products manufactured in the new manufacturing facility will be sold under the brand name SonoRad, and are designed for large hospitals, healthcare institutions and individual radiology centres
An RMAT confers eligibility for accelerated approval and priority review of biologics licensing applications (BLA)
Turn has developed a novel cell rejuvenating platform with significant potential for application in an array of age-related diseases
Nuvaxovid is the first protein-based Covid-19 vaccine authorized for use in Switzerland
Ideal power boosters to strengthen muscles and keep energised for all kinds of physical activities
Collaboration awarded €3 million grant by the Bill & Melinda Gates Foundation
New Covid-19 Medriva Rapid Antigen Test kits with very high- sensitivity now available in Australia
GRC 54276 has shown tumour cell killing ability in preclinical studies as a single agent and as well in combination with checkpoint inhibitors, making it a high-priority target in immuno-oncology
Subscribe To Our Newsletter & Stay Updated